TY - JOUR
T1 - CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
AU - Zhang, Li
AU - Mosquera, Isabel
AU - Lucas, Eric
AU - Rol, Mary Luz
AU - Carvalho, Andre L.
AU - Basu, Partha
AU - CanScreen5 collaborators
A2 - Sadowski, Daniel
A2 - Natasha, Bartlett
A2 - Budd, Alison
A2 - Nessa, Ashrafun
A2 - De Brabander, Isabel
A2 - Haelens, Annemie
A2 - Pringels, Sarah
A2 - Tairo, Jonas
A2 - Hofvind, Solveig
A2 - Burrion, J. B.
A2 - Valerianova, Zdravka
A2 - Tinmouth, Jill
A2 - Law, Cindy
A2 - Ebenuwah, Simbi
A2 - McCurdy, Bronwen
A2 - Janik, Beata
A2 - Pupwe, George
A2 - Groeneveld, Linn Fenna
A2 - Skare, Gry Baadstrand
A2 - Layne, Penelope
A2 - Sarkeala, Tytti
A2 - Chaila, Mwate Joseph
A2 - Kaminski, Michal
A2 - Kinel, Beata
A2 - Lissowska, Jolanta
A2 - Mumukunde, Inga
A2 - Rodrigues, Vitor
A2 - Rodríguez, Robinson
A2 - Sanz, Elena Pérez
A2 - Alberdi, Raquel Zubizarreta
A2 - Ronco, Guglielmo
A2 - Antoljak, Nataša
A2 - Nakić, Dinka
A2 - Plazanin, Davor
A2 - Parun, Andrea Šupe
A2 - Goossens, Mat
A2 - Nowakowski, Andrzej
A2 - de Koning, Harry
A2 - Dams, Els
A2 - Martin, Asha
A2 - Epermane, Mara
A2 - Jankovska, Nataļja
A2 - Antle, Scott
A2 - Rezeberga, Dace
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/5
Y1 - 2023/5
N2 - The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.
AB - The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.
UR - http://www.scopus.com/inward/record.url?scp=85153764106&partnerID=8YFLogxK
U2 - 10.1038/s41591-023-02315-6
DO - 10.1038/s41591-023-02315-6
M3 - Article
C2 - 37106168
AN - SCOPUS:85153764106
SN - 1078-8956
VL - 29
SP - 1135
EP - 1145
JO - Nature Medicine
JF - Nature Medicine
IS - 5
ER -